The MCS (Medicinal Chemistry & Synthesis) group is focused on chemical research to generate knowledge and therapeutic technologies combining the improvement and optimization of existing drug molecules and the definition of new therapeutic approaches. The MCS, under the direction of Dr. Amadeu Llebaria, is comprised of the Laboratory of Medicinal Chemistry (MedChemLab) and the Service of Synthesis of High Added Value Molecules (SIMChem), both pertaining to the Institute of Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC).

The basic and applied research is oriented to obtain biologically active compounds and their application in therapy through the development of drugs, working in all areas of Medicinal Chemistry.

On the other hand, the MCS collaborates with public and private health sectors providing chemical support to R+D+i activities in industry, university and other research organizations.

The MCS has been selected as a TECNIO pre-candidate group. TECNIO is a certification granted by the Catalan government (Generalitat de Catalunya) which identifies expert technological centres and academic groups involved in applied research in Catalonia, with the aim to promote the transfer of technology from academia to industry.

Supported by:

accio_ logo_generalitat_3